MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Impact of Patient-Specific Structural Connectivity of STN-DBS on Balance and Mobility – Pilot study

    š. Janovič, S. Holly, M. Chmelík, D. Juskanič, L. Pátrovič, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)

    Objective: To evaluate the impact of patient-specific structural connectivity between VTA in STN targeting and SMA/preSMA on functional mobility improvements in PD patients undergoing DBS.…
  • 2025 International Congress

    Description Genotype/phenotype of patients with Parkinson’s disease. Report of an Argentinean cohort included in the LARGE PD Consortium.

    M. Espindola, N. Gonzalez Rojas, G. da Prat, M. Cesarini, J. Etcheverry, I. Mata, C. Perandones, E. Gatto (Cleveland, USA)

    Objective: To characterize the genetic and phenotypic profile of Argentinean Parkinson's patients and contribute to the understanding of the genetic heterogeneity of this disease. Background:…
  • 2025 International Congress

    Assessing the potential association of rs2298383 in ADORA2A as a predictor of Levodopa-Induced Dyskinesia in Latin American Parkinson’s Disease patients

    HM. Chaparro-Solano, E. Waldo, T. Peixoto-Leal, AF. Schumacher-Schuh, BL. Santos-Lobato, E. Gatto, G. Arboleda, JL. Orozco-Velez, P. Chana-Cuevas, D. Aguillon, M. Rodriguez-Violante, D. Martinez-Ramirez, M. Cornejo-Olivas, A. Vinuela, G. Alvarado, P. Olguín, S. Alcauter, IF. Mata (Cleveland, USA)

    Objective: To analyze the association between ADORA2A-rs2298383 and levodopa induced dyskinesias (LID) in a cohort of Latin American Parkinson’s disease patients. Background: Previous evidence has…
  • 2025 International Congress

    Prevalence and Characteristics of Glucocerebrosidase Genetic Variants in Nepalese Early-onset Parkinson’s Disease Patients

    R. Ojha, B. Gajurel, N. Gautam, R. Karn, R. Rajbhandari, S. Shahi, V. Sharma, S. Baidya, A. Bhattarai, A. Niraula, E. Tuladhar, A. Adhikari, Y. Tay, S. Lim, A. Tan (Kathmandu, Nepal)

    Objective: To evaluate the genotype and phenotype of early-onset Parkinson´s Disease (EOPD) in the Nepalese population. Background: A significant proportion of early-onset PD (EOPD) can…
  • 2025 International Congress

    Clinical and neuro-imaging predictors of falls in PLA2G6-related Parkinsonism: a retrospective study

    C. Chen, Y. Sun, H. Dai, F. Liu, . Jun, X. Liu, J. Wang (Shanghai, China)

    Objective: This study investigates clinical and neuroimaging predictors of recurrent falls and gait disturbances in PLA2G6-related Parkinsonism. Background: PLA2G6-related Parkinsonism is characterized by dystonia-parkinsonism, cerebellar…
  • 2025 International Congress

    Insights into Ancestral Diversity in Parkinson’s Disease Risk: A Comparative Assessment of Polygenic Risk Scores

    S. Grant, P. Saffie-Awad, M. Makarious, I. Elsayed, A. Sanyaolu, P. Wild Crea, A. Schumacher Schuh, K. Levine, D. Vitale, M. Koretsky, J. Kim, T. Leal, M. Periñan, S. Dey, A. Noyce, A. Reyes-Palomares, N. Rodriguez-Losada, J. Foo, W. Mohamed, K. Heilbron, L. Norcliffe-Kaufmann, M. Rizig, N. Okubadejo, M. Nalls, C. Blauwendraat, A. Singleton, H. Leonard, I. Mata, S. Bandres-Ciga (Bethesda, USA)

    Objective: This study aims to provide a comprehensive assessment of PRS performance across ancestries and highlight the limitations of a “one-size-fits-all” approach to genetic risk…
  • 2025 International Congress

    Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations

    F. Akcimen (Bethesda, USA)

    Objective: The influence of genetics has been primarily studied in European populations, limiting our understanding of the genetic landscape of PD in the African and…
  • 2025 International Congress

    Automated Image-Guided Programming Algorithm Supports Clinicians During DBS Programming for Parkinson’s Disease Patients

    J. Aldred, C. Luca, A. Ramirez-Zamora, J. Wong, K. Wessels, T. Peabody, B. Reese, B. Farber Petrey, R. Mustakos, S. Niketeghad, R. Shivacharan, M. Malekmohammadi (Valencia, USA)

    Objective: To assess clinical outcomes of an acute automated image-guided programming (aIGP) algorithm in PD patients implanted with a deep brain stimulation (DBS) system. Background:…
  • 2025 International Congress

    Efficacy and outcomes of deep brain stimulation in elderly Parkinson’s disease: An institutional based study

    M. Karri, R. Kandadai, R. Borgohain, S. Kola, R. Alugolu, P. Vvsrk, T. Syed, S. Mohareer, Y. Kancharla (Hyderabad, India)

    Objective: Advanced therapies like DBS have been approved modalities for PD. Most studies focused on age below 65, reporting improvement in motor symptoms with persistent…
  • 2025 International Congress

    Eight-Year Outcome of Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson’s Disease Patients

    I. Schlesinger, M. Nassar, A. Sinai, I. Senderova, M. Katson, M. Constantinescu, M. Zaaroor, L. Lev Tov (Haifa, Israel)

    Objective: To assess the 8-year outcome of unilateral MRI guided focused ultrasound (MRgFUS) ventral intermediate nucleus thalamotomy in tremor dominant Parkinson's disease (TDPD) patients, with…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley